FDA Investigator Martha T Olone

Martha T Olone has inspections in 3 countries as of 13 Oct 2023. Martha T Olone has collaborated with a combinined 3555 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
11
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Austria, Canada
Co-Investigator(s):
A Williams, Aimee Cunningham, PhD, Alicia M Mozzachio, Amanda Dinaro, Amanda S Zorn, Amber D Brodas, Amy Devlin, PhD, Amy M Cramer, Ana S Cabrera, Anissa M Cheung, Ann Marie Montemurro, Ann Marie Schofield, Anna Flynn, Annemarie Bodnar, Antonina Aydanian, Arie C Menachem, Atul J Agrawal, Azza Talaat, Brenda P King, Brentley S Collins, Brently S Collins, Brian D Nicholson, Bruce H Mccullough, Burnell M Henry, Byungja E Marciante, Carolyn A Renshaw, Carrie Ann Plucinski, Cassandra Overking, CDR Jeremy L Wally, PhD, Chad E Schmear, Chad R Burger, Charles Jewell, Chiang Syin, PhD, Christian D Lynch (CDL), Christina Capacci Daniel, PhD, Christina D Lynch, Christopher Downey, PhD, Creighton T Tuzon, Cynthia Jim, CSO, Daniel C Kearns, Daniel Kearns, Dawn L Wydner, Dawn M Braswell, Deborah M Trout, Debra Boyd Seale, Debra I Love, Debra L Boyd Seale, Demitria J Argiropoulos, Demitria J Xiradakis, Dennis E Guilfoyle, PhD, Diane L Raccasi, Donald L Lech, Dr. Guang Gao, PhD, Dr. Willie F Vann, PhD, Ekaterina Allen, Eliezar Ramos, Ellen P Madigan, Elliot P Cowam, PhD, Eric J Cunningham, Eric M Mueller, PharmD, Esra Toussaint, Frank J Marciniak, Freyja V Lynn, Gene D Arcy, Gunther Bockhoudt, Gunther Boekhoudt, PhD, Harperd, Helen B Ricalde, Humera Khan, Humera T Khan, J David Doleski, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James C Maclaughlin, James E Keller, PhD, James W Plucinski, Jan B Welch, Jan Welch, Janet L Bowen, Jason F Chancey, Jean M Kelahan, Jeanne M Morris, Jee Chung, PhD, Jennifer L Bridgewater, Jennifer L Schmidt, Jennifer Macmillan, Jesse A Vazquez, Joan A Loreng, Joanne Pryzbylik, Jonathan G Matrisciano, Jose R Hernandez, Joseph A Morkunas, Joyce A Rockwell, Julie D Bringger, Justine M Corson, Kara A Scheibner, PhD, Karen Emasley Joseph, Karen Emaslwey Joseph, Karen L Kosar, Kathleen B Swat, Kathleen R Jones, PhD, Kelly I Anderson, Kevin A Gonzalez, Kimberly Lewandowski Walker, Kimberly M Bigler, Kinh Q Mac, Kristina L Conroy, Kujtim Sadiku, Lagurta M Mayher, Lakisha M Williams, Lata C Mathew, PhD, Lauren L Vajo, Laurie A Haxel, LCDR Debra Emerson, Lequita M Mayhew, Leslie D Wagner, Li Li, Linda Thai, Lindsey R Lyman, Lisa Hornback, Lorelei S Jarrell, Loretta Nemchik, Lori P Peters, Margaret Mtorres Vazquez, Margaret Torres Vazquez, Maria Joselopez Barragan, PhD, Marion Michaelis, Mariza M Jafary, Marjorie A Shapiro, PhD, Marsha W Major, Martha O'lone, Mary Davis Lopez, Mary T Carden, Mate Tolnay, Matthew A Spataro, Maureen C Melvin, Maxwell Van Tassell, PhD, Megan A Haggerty, Meihong Liu, Michael D Robinson, Michael Schmitt, Michele L Forster, PhD, Michelle M Noe, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Milan S Blake, Monique C Lo, Nailing Zhang, Nancy T Waites, Nicholas F Lyons, Nicole J Clausen, Nicole K Trudel, Nicole S Williams, Norman Wong, Omotunde O Osunsanmi, Paul Mouris, Paula A Trost, Perry T Nichols, Prabhu P Raju, Priscilla M Pastrana, Qiao Y Bobo, Rafael Padilla, Richard D Manney, Richard H Penta, Richard W Thornton, Robert Jennings, Robert L Stevenson, Robert W Jennings, Roberta W Cunningham, Roger F Zabinski, Rose M Ashley, Russell K Riley, Sarah B Tanksley, Sarah Forney, Scott E Norris, Sean R Bryd, Sean R Marcsisin, Seth A Mailhot, Sheryl A Kochman, Simone E Pitts, Stacey S Degarmo, Stephen D Eich, Susan A Zullo, PhD, Susan F Laska, MS, Susan M Jackson, Susan Yu, Tamara Brey, Teresita C Mercado, Tina S Roecklein, Todd M Stankewicz, Travis S Bradley, Victor J Gangi, Walter Lange, Wayne E Seifert, Yanming An, PhD, Yvins Dezan, Ze Peng, Zhihao Qiu (Peter), PhD

Martha T Olone's Documents

Publish Date Document Type Title
May, 2008 FDA 483 ID Biomedical - Form 483, 2008-05-22

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more